
### [MONDO:0015901](http://purl.obolibrary.org/obo/MONDO_0015901)
**Label:** rare hyperlipidemia

**Subclasses:** [MONDO:0016203](http://purl.obolibrary.org/obo/MONDO_0016203) (hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency), [MONDO:0018328](http://purl.obolibrary.org/obo/MONDO_0018328) (homozygous familial hypercholesterolemia), [MONDO:0014412](http://purl.obolibrary.org/obo/MONDO_0014412) (hyperlipoproteinemia, type 1D), [MONDO:0018799](http://purl.obolibrary.org/obo/MONDO_0018799) (rare hypercholesterolemia), [MONDO:0014790](http://purl.obolibrary.org/obo/MONDO_0014790) (TMEM199-CDG), [MONDO:0019247](http://purl.obolibrary.org/obo/MONDO_0019247) (combined hyperlipidemia), [MONDO:0009387](http://purl.obolibrary.org/obo/MONDO_0009387) (familial lipoprotein lipase deficiency), [MONDO:0011374](http://purl.obolibrary.org/obo/MONDO_0011374) (autosomal recessive hypercholesterolemia), [MONDO:0018473](http://purl.obolibrary.org/obo/MONDO_0018473) (hyperlipoproteinemia type 3), [MONDO:0008810](http://purl.obolibrary.org/obo/MONDO_0008810) (familial apolipoprotein c-II deficiency), [MONDO:0007759](http://purl.obolibrary.org/obo/MONDO_0007759) (hyperlipidemia, familial combined), [MONDO:0007327](http://purl.obolibrary.org/obo/MONDO_0007327) (chylomicronemia, familial, due to Circulating inhibitor of lipoprotein lipase), [MONDO:0007744](http://purl.obolibrary.org/obo/MONDO_0007744) (cholesterol-ester transfer protein deficiency), [MONDO:0007788](http://purl.obolibrary.org/obo/MONDO_0007788) (hypertriglyceridemia, familial), [MONDO:0007762](http://purl.obolibrary.org/obo/MONDO_0007762) (hyperlipoproteinemia type v), [MONDO:0015903](http://purl.obolibrary.org/obo/MONDO_0015903) (hyperalphalipoproteinemia), [MONDO:0015308](http://purl.obolibrary.org/obo/MONDO_0015308) (laminopathy type Decaudain-Vigouroux), [MONDO:0015902](http://purl.obolibrary.org/obo/MONDO_0015902) (major hypertriglyceridemia), [MONDO:0013533](http://purl.obolibrary.org/obo/MONDO_0013533) (hyperlipidemia due to hepatic triglyceride lipase deficiency), [MONDO:0013534](http://purl.obolibrary.org/obo/MONDO_0013534) (apolipoprotein c-Iii deficiency), [MONDO:0011207](http://purl.obolibrary.org/obo/MONDO_0011207) (xanthomatosis, susceptibility to), [MONDO:0014789](http://purl.obolibrary.org/obo/MONDO_0014789) (CCDC115-CDG), [MONDO:0018637](http://purl.obolibrary.org/obo/MONDO_0018637) (familial chylomicronemia syndrome), 

**Corr. equiv. classes:** [Orphanet:477811](http://www.orpha.net/ORDO/Orphanet_477811), [Orphanet:79506](http://www.orpha.net/ORDO/Orphanet_79506), [OMIM:602247](http://purl.obolibrary.org/obo/OMIM_602247), [Orphanet:309020](http://www.orpha.net/ORDO/Orphanet_309020), [Orphanet:444490](http://www.orpha.net/ORDO/Orphanet_444490), [OMIM:118830](http://purl.obolibrary.org/obo/OMIM_118830), [Orphanet:140905](http://www.orpha.net/ORDO/Orphanet_140905), [OMIM:603813](http://purl.obolibrary.org/obo/OMIM_603813), [Orphanet:466703](http://www.orpha.net/ORDO/Orphanet_466703), [OMIM:144250](http://purl.obolibrary.org/obo/OMIM_144250), [OMIM:207750](http://purl.obolibrary.org/obo/OMIM_207750), [OMIM:615947](http://purl.obolibrary.org/obo/OMIM_615947), [Orphanet:468684](http://www.orpha.net/ORDO/Orphanet_468684), [Orphanet:412](http://www.orpha.net/ORDO/Orphanet_412), [OMIM:144650](http://purl.obolibrary.org/obo/OMIM_144650), [Orphanet:79211](http://www.orpha.net/ORDO/Orphanet_79211), [Orphanet:181428](http://www.orpha.net/ORDO/Orphanet_181428), [Orphanet:391665](http://www.orpha.net/ORDO/Orphanet_391665), [Orphanet:181425](http://www.orpha.net/ORDO/Orphanet_181425), [Orphanet:309015](http://www.orpha.net/ORDO/Orphanet_309015), [OMIM:614025](http://purl.obolibrary.org/obo/OMIM_614025), [Orphanet:137871](http://www.orpha.net/ORDO/Orphanet_137871), [OMIM:143470](http://purl.obolibrary.org/obo/OMIM_143470), [OMIM:614028](http://purl.obolibrary.org/obo/OMIM_614028), [OMIM:616828](http://purl.obolibrary.org/obo/OMIM_616828), [Orphanet:209902](http://www.orpha.net/ORDO/Orphanet_209902), [OMIM:238600](http://purl.obolibrary.org/obo/OMIM_238600), [Orphanet:70470](http://www.orpha.net/ORDO/Orphanet_70470), [OMIM:145750](http://purl.obolibrary.org/obo/OMIM_145750), [OMIM:616829](http://purl.obolibrary.org/obo/OMIM_616829), 

**Class expressions from DL-Learner:**

- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0003011](http://purl.obolibrary.org/obo/HP_0003011) (Abnormality of the musculature))) 64.16%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs))) 63.03%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0011729](http://purl.obolibrary.org/obo/HP_0011729) (Abnormality of joint mobility))) 63.03%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0009121](http://purl.obolibrary.org/obo/HP_0009121) (Abnormal axial skeleton morphology))) 63.03%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0002817](http://purl.obolibrary.org/obo/HP_0002817) (Abnormality of the upper limb))) 63.03%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0012823](http://purl.obolibrary.org/obo/HP_0012823) (Clinical modifier))) 61.98%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0012144](http://purl.obolibrary.org/obo/HP_0012144) (Abnormality of cells of the monocyte/macrophage lineage))) 61.98%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0011805](http://purl.obolibrary.org/obo/HP_0011805) (Abnormality of muscle morphology))) 61.98%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0011138](http://purl.obolibrary.org/obo/HP_0011138) (Abnormality of skin adnexa morphology))) 61.98%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0011119](http://purl.obolibrary.org/obo/HP_0011119) (Abnormality of the nasal dorsum))) 61.98%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation))) 61.98%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0010987](http://purl.obolibrary.org/obo/HP_0010987) (Abnormality of cellular immune system))) 61.98%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0010974](http://purl.obolibrary.org/obo/HP_0010974) (Abnormality of myeloid leukocytes))) 61.98%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0010938](http://purl.obolibrary.org/obo/HP_0010938) (Abnormality of the external nose))) 61.98%
- [HP:0010980](http://purl.obolibrary.org/obo/HP_0010980) (Hyperlipoproteinemia) and (not ([HP:0010929](http://purl.obolibrary.org/obo/HP_0010929) (Abnormality of cation homeostasis))) 61.98%


